The Australian Research Data Commons (ARDC) invites you to participate in a short survey about your
interaction with the ARDC and use of our national research infrastructure and services. The survey will take
approximately 5 minutes and is anonymous. It’s open to anyone who uses our digital research infrastructure
services including Reasearch Link Australia.
We will use the information you provide to improve the national research infrastructure and services we
deliver and to report on user satisfaction to the Australian Government’s National Collaborative Research
Infrastructure Strategy (NCRIS) program.
Please take a few minutes to provide your input. The survey closes COB Friday 29 May 2026.
Complete the 5 min survey now by clicking on the link below.
A-Prof Roberst is a clinical haematologist caring for patients with blood cancers, who is committed to developing new therapies for currently incurable diseases through laboratory and clinical trial research.
The Roles Of Retinoic Acid Receptors In Regulating Haemopoiesis And Bone
Funder
National Health and Medical Research Council
Funding Amount
$601,484.00
Summary
My research has shown that vitamin A is very important to the normal function of blood and bone cells. I will further explore the uses of vitamin A products to improve the treatment of patients with a range of different blood and bone diseases. These studies may lead to better treatments of patients with a wide range of blood cell diseases. It may also reveal better treatments for patients with bone diseases such as cancer and osteoporosis.
I am a hematologist with expertise in the science of immunology and clinical experience in bone marrow transplantation and the treatment of hematological malignancies. My vision is to study the biology of dendritic cells, which are the specialized white cells that initiate the immune response, and then, to apply this knowledge to the design and introduction of novel diagnostic and therapeutic immune strategies, to improve the survival of patients with leukemia, lymphoma and multiple myeloma.